Cipla has informed that the Nomination and Remuneration Committee of the Company on February 08, 2017 allotted 39,691 equity shares of Rs 2 each pursuant to exercise of the stock options by the option grantees under Employee Stock Option Scheme 2013-A. Consequently, the issued share capital of the Company stands increased to Rs 1,61,09,50,272 comprising of 80,54,75,136 equity shares of face value Rs 2 each. The paid-up & subscribed share capital of the Company stands increased to Rs 1,60,89,43,482 comprising of 80,44,71,741 equity shares of face value Rs 2 each.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1903.00 |
| Dr. Reddys Labs. | 1353.75 |
| Cipla | 1452.35 |
| Zydus Lifesciences | 1152.90 |
| Lupin | 2489.85 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: